{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ04343",
      "entity_text" : "anti-DNA Ab",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:76720" ],
      "Organ" : [ "uberon:UBERON:0006611" ]
    }
  },
  "verbose_text" : "Moreover, the ADA positive but not ADA negative patients developed significantly increased levels of anti-DNA Ab (Farr) during IFX treatment, and the highest post-treatment levels were significantly higher compared with the ADA negative patients (XREF_FIG).",
  "reading_complete" : "2020-08-08T15:34:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:30:58Z",
  "trigger" : "levels",
  "evidence" : [ "levels of anti-DNA Ab" ],
  "pmc_id" : "5028026",
  "score" : 0
}